Seven Fleet Capital Management LP
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed April 2, 2026), Seven Fleet Capital Management LP reported 85 stock positions worth $147.8 million. Its top holding was CG Oncology (CGON) at 42.6% of the portfolio, followed by Cogent Biosciences (COGT, 5.1%) and Soleno Therapeutics (SLNO, 4.1%).
- Most Recent 13F
- Q2 2026
- Location
- MOUNTAIN VIEW, CA
- CIK
- 0002092021
- Portfolio Value
- $147.8M (Q4 2025)
- SEC Filing
- 0001013594-26-000420 ↗ filed Apr 2, 2026
Holdings Value
Holdings 85 stocks · $147.8M
| CGON CG Oncology Inc. | 42.57% | 1,515,151 | $62.9M | — |
| COGT Cogent Biosciences Inc. | 5.15% | 214,099 | $7.6M | — |
| SLNO Soleno Therapeutics Inc. | 4.08% | 130,079 | $6.0M | — |
| TERN Terns Pharmaceuticals Inc. | 3.57% | 130,413 | $5.3M | — |
| RVMD Revolution Medicines Inc. | 3.55% | 65,800 | $5.2M | — |
| LQDA Liquidia Corp. | 2.13% | 91,267 | $3.1M | — |
| CMPX Compass Therapeutics Inc. | 2.07% | 568,747 | $3.1M | — |
| EXEL Exelixis Inc. | 2.03% | 68,569 | $3.0M | — |
| ASMB Assembly Biosciences Inc. | 1.70% | 73,762 | $2.5M | — |
| AXSM Axsome Therapeutics Inc. | 1.60% | 12,955 | $2.4M | — |
| TYRA Tyra Biosciences Inc. | 1.42% | 79,560 | $2.1M | — |
| TNGX Tango Therapeutics Inc. | 1.29% | 215,172 | $1.9M | — |
| ABVX Abivax SA-ADR | 1.23% | 13,499 | $1.8M | — |
| XNCR Xencor Inc. | 1.14% | 109,554 | $1.7M | — |
| ELVN Enliven Therapeutics Inc. | 1.04% | 99,953 | $1.5M | — |
| PHVS Pharvaris NV | 1.04% | 55,342 | $1.5M | — |
| MLYS Mineralys Therapeutics Inc. | 1.03% | 42,025 | $1.5M | — |
| BLTE Belite Bio Inc. - ADR | 0.99% | 9,161 | $1.5M | — |
| DYN Dyne Therapeutics Inc. | 0.93% | 70,180 | $1.4M | — |
| NUVL Nuvalent Inc. Class A | 0.86% | 12,601 | $1.3M | — |
| ASND Ascendis Pharma A/S | 0.82% | 5,670 | $1.2M | — |
| FOLD Amicus Therapeutics Inc. | 0.80% | 82,500 | $1.2M | — |
| PCVX Vaxcyte Inc. | 0.79% | 25,365 | $1.2M | — |
| AVTX Avalo Therapeutics Inc. | 0.78% | 63,343 | $1.2M | — |
| IKT Inhibikase Therapeutics Inc. | 0.74% | 533,648 | $1.1M | — |
| MDGL Madrigal Pharmaceuticals Inc. | 0.73% | 1,860 | $1.1M | — |
| GERN Geron Corp. | 0.69% | 777,880 | $1.0M | — |
| KRYS Krystal Biotech Inc. | 0.67% | 4,000 | $986K | — |
| LONA Leonabio Inc. filed as ATHIRA PHARMA INC | 0.66% | 127,951 | $969K | — |
| TSHA Taysha Gene Therapies Inc. | 0.62% | 167,223 | $920K | — |
| SLN Silence Therapeutics PLC-ADR | 0.61% | 147,600 | $897K | — |
| ZURA Zura Bio Ltd. | 0.59% | 166,500 | $872K | — |
| AGIO Agios Pharmaceuticals Inc. | 0.58% | 31,738 | $864K | — |
| CELC Celcuity Inc. | 0.56% | 8,338 | $832K | — |
| PRAX Praxis Precision Medicines I | 0.54% | 2,700 | $796K | — |
| KALV Kalvista Pharmaceuticals Inc. | 0.53% | 48,412 | $782K | — |
| PALI Palisade Bio Inc. | 0.52% | 327,500 | $770K | — |
| RLMD Relmada Therapeutics Inc. | 0.50% | 154,109 | $744K | — |
| PTGX Protagonist Therapeutics Inc. | 0.47% | 8,000 | $699K | — |
| CDTX Cidara Therapeutics Inc. | 0.45% | 3,026 | $668K | — |
| CYTK Cytokinetics Inc. | 0.44% | 10,335 | $657K | — |
| NKTR Nektar Therapeutics | 0.43% | 15,000 | $634K | — |
| UTHR United Therapeutics Corp. | 0.43% | 1,300 | $633K | — |
| RLAY Relay Therapeutics Inc. | 0.42% | 73,000 | $618K | — |
| DNTH Dianthus Therapeutics Inc. | 0.41% | 14,651 | $604K | — |
| MBX MBX Biosciences Inc. | 0.39% | 18,200 | $574K | — |
| EOLS Evolus Inc. | 0.37% | 82,000 | $545K | — |
| ZYME Zymeworks Inc. | 0.37% | 20,600 | $542K | — |
| CRBP Corbus Pharmaceuticals Holdi | 0.31% | 56,750 | $462K | — |
| VRDN Viridian Therapeutics Inc. | 0.31% | 14,654 | $456K | — |
| PRTA Prothena Corp. PLC | 0.28% | 43,300 | $414K | — |
| NRIX Nurix Therapeutics Inc. | 0.26% | 20,000 | $379K | — |
| SVRA Savara Inc. | 0.26% | 62,762 | $378K | — |
| TARS Tarsus Pharmaceuticals Inc. | 0.25% | 4,500 | $368K | — |
| PLRX Pliant Therapeutics Inc. | 0.23% | 276,500 | $337K | — |
| ACRS Aclaris Therapeutics Inc. | 0.22% | 107,419 | $323K | — |
| SEPN Septerna Inc. | 0.22% | 11,445 | $319K | — |
| CLYM Climb Bio Inc. | 0.21% | 76,400 | $306K | — |
| CMPS Compass Pathways PLC | 0.19% | 40,000 | $276K | — |
| BEAM Beam Therapeutics Inc. | 0.18% | 9,537 | $264K | — |
| ENTX Entera Bio Ltd. | 0.18% | 135,318 | $263K | — |
| VKTX Viking Therapeutics Inc. | 0.14% | 6,000 | $211K | — |
| QURE Uniqure NV | 0.14% | 8,742 | $209K | — |
| CTMX Cytomx Therapeutics Inc. | 0.14% | 48,898 | $208K | — |
| OCUL Ocular Therapeutix Inc. | 0.14% | 17,100 | $208K | — |
| ORKA Oruka Therapeutics Inc. | 0.11% | 5,240 | $159K | — |
| NAMS Newamsterdam Pharma Co. NV | 0.10% | 4,000 | $140K | — |
| AMLX Amylyx Pharmaceuticals Inc. | 0.09% | 11,571 | $140K | — |
| APGE Apogee Therapeutics Inc. | 0.09% | 1,800 | $136K | — |
| ALXO Alx Oncology Holdings Inc. | 0.09% | 117,817 | $133K | — |
| VSTM Verastem Inc. | 0.08% | 15,140 | $117K | — |
| RGC Regencell Bioscience Holding | 0.06% | 4,400 | $92K | — |
| TRVI Trevi Therapeutics Inc. | 0.06% | 7,110 | $89K | — |
| IMUX Immunic Inc. | 0.06% | 155,223 | $83K | — |
| PMVP PMV Pharmaceuticals Inc. | 0.05% | 63,498 | $79K | — |
| GLUE Monte Rosa Therapeutics Inc. | 0.04% | 4,000 | $63K | — |
| TRAW Traws Pharma Inc. | 0.04% | 49,260 | $56K | — |
| ATXS Astria Therapeutics Inc. | 0.04% | 4,000 | $52K | — |
| EWTX Edgewise Therapeutics Inc. | 0.03% | 2,000 | $50K | — |
| VTGN Vistagen Therapeutics Inc. | 0.03% | 62,701 | $42K | — |
| ENTA Enanta Pharmaceuticals Inc. | 0.02% | 2,270 | $36K | — |
| CGEM Cullinan Therapeutics Inc. | 0.02% | 3,000 | $31K | — |
| GBIO Generation Bio Co. | 0.02% | 5,376 | $31K | — |
| ELDN Eledon Pharmaceuticals Inc. | 0.01% | 6,000 | $9K | — |
| VIR Vir Biotechnology Inc. | 0.00% | 200 | $1K | — |
Portfolio Sells Q4 2025
No earlier filing to compare with.
Portfolio Buys Q4 2025
No earlier filing to compare with.